Go to  Advanced Search

Lanthanides and their complexes for the treatment of bone density disorders

Show full item record

Files in this item

Files Size Format Description   View
ubc_2012_fall_mawani_yasmin.pdf 5.129Mb Adobe Portable Document Format   View/Open
Title: Lanthanides and their complexes for the treatment of bone density disorders
Author: Mawani, Yasmin Jenny
Degree: Doctor of Philosophy - PhD
Program: Chemistry
Copyright Date: 2012
Issue Date: 2012-08-24
Publicly Available in cIRcle 2013-10-18
Publisher University of British Columbia
Abstract: Lanthanides are of interest in the treatment of bone density disorders because they are found to accumulate preferentially in bone (in vivo), have a stimulatory effect on bone formation, and exhibit an inhibitory effect on bone degradation (in vitro), altering the homeostasis of the bone cycle. In an effort to develop an orally active lanthanide drug, a series of 3-hydroxy-4- pyridinone ligands were synthesized and eight of these ligands (H1 = 3-hydroxy-2-methyl-1- (2-hydroxyethyl)-4-pyridinone, H2 = 3-hydroxy-2-methyl-1-(3-hydroxypropyl)-4-pyridinone, H3 = 3-hydroxy-2-methyl-1-(4-hydroxybutyl)-4-pyridinone, H4 = 3-hydroxy-2- methyl-1-(2-hydroxypropyl)-4-pyridinone, H5 = 3-hydroxy-2-methyl-1-(1-hydroxy-3- methylbutan-2-yl)-4-pyridinone, H6 = 3-hydroxy-2-methyl-1-(1-hydroxybutan-2-yl)-4- pyridinone, H8 = 1-carboxymethyl-3-hydroxy-2-methyl-4-pyridinone, H9 = 1-carboxyethyl- 3-hydroxy-2-methyl-4-pyridinone) were coordinated to ³⁺(Ln = La, Eu, Gd, Lu) forming stable tris-ligand complexes (LnL­­₃, L = 1-, 2-, 3-, 4-, 5-, 6-, 8- and 9-). The dissociation (pKan) and metal ligand stability constants (log βn) of the 3-hydroxy-4-pyridinones with La³⁺ and Gd³⁺ were determined by potentiometric titrations, which demonstrated that the 3-hydroxy-4- pyridinones form stable tris-ligand complexes with the lanthanide ions. One phosphinate- EDTA derivative (H₅XT = bis[[bis(carboxymethyl)amino]methyl]phosphinate) was also synthesized and coordinated to Ln³⁺ (Ln = La, Eu, Lu), forming the potassium salt of [Ln(XT)]²-. Lastly, the naturally occurring curcuminoids found in turmeric were separated into the three naturally occurring components (HCurc = (1E,6E)-1-(4-hydroxy-3- methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione, HDMC = (1E,6E)-1,7- bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione, HBDMC = (1E,6E)-1,7-bis(4- hydroxy-phenyl)hepta-1,6-diene-3,5-dione); HCurc was then coordinated to Ln³⁺ (Ln = Eu, Gd, Yb, Lu), forming Ln(Curc)­­₃ complexes. The free ligands and metal complexes were studied for their in vitro efficacy. Cytotoxicity assays were carried out in MG-63 cells; with the exception of the curcuminoids, all the ligands and metal complexes tested were observed to be non-toxic to this cell line. Further studies to investigate the toxicity, cellular uptake and iii apparent permeability (Papp) of the lanthanide ions were conducted in Caco-2 cells and it was observed that [La(XT)]²- had the greatest cell uptake. Investigation into the binding affinities of free lanthanide ions (Ln = La, Gd and Lu), metal complexes and free 3-hydroxy-4-pyridinones with the bone mineral (HAP) indicate a strong binding affinity of the lanthanide ions for HAP, as well as a moderate to strong interaction of the free ligand with the bone mineral depending on the functional group.
Affiliation: Science, Faculty of
URI: http://hdl.handle.net/2429/43054
Scholarly Level: Graduate

This item appears in the following Collection(s)

Show full item record

UBC Library
1961 East Mall
Vancouver, B.C.
Canada V6T 1Z1
Tel: 604-822-6375
Fax: 604-822-3893